Technology
New On Robinhood
Health

Synthorx

$20.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.45 (-2.11%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Synthorx and other stocks, options, ETFs, and crypto commission-free!

About

Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. Read More The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA.

Employees
38
Headquarters
La Jolla, California
Founded
2014
Market Cap
669.02M
Price-Earnings Ratio
Dividend Yield
Average Volume
150.77K
High Today
$21.99
Low Today
$20.45
Open Price
$21.32
Volume
73.48K
52 Week High
$23.53
52 Week Low
$11.00

Collections

Technology
New On Robinhood
Health
Biotechnology
Biopharmaceutical
Cancer Prevention
Pharmaceutical
2018 IPO

Earnings

Q4 2018
Estimated
Actual
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.